Westin Miyako Kyoto,
Kyoto, Japan
Visit Nikon / Berkeley Lights at BPI Asia 2020
Stop by Booth #3 or and Attend our Presentation on 26 February at 12:00-12:30
About Nikon Corporation
Nikon has developed observation of the micro world since the launch of our first microscopes in 1925. Today, we are supporting customers engaging in cell culture and regenerative medicine through our technologies for observation and evaluation of cells. Nikon started project for Antibody drugs field as a strategic partner of Berkeley Lights.
![](https://knect365.imgix.net/uploads/nikon-logo-8510f3c8b1f03d41b1429d33e83ef6f4.jpg?auto=format&fit=max)
About Berkeley Lights
Berkeley Lights, Inc. develops and commercializes workflows to find the best cells.
By operating at the intersection of biology, technology and information, our workflows accelerate the design, discovery, development, and delivery of cell-based products enabling the deployment of biology for the production of sustainable sources of food, therapies, and energy.
![](https://knect365.imgix.net/uploads/berkeley-lights-logo-5fdbf63ca61e1e9c79b7c57e037a1530.jpg?auto=format&fit=max)
Get the Latest Event Updates
Attend Nikon / Berkeley Lights' Presentation at BPI Asia 2020
26 February at 12:00-12:30
Establishing A New Standard: Unparalleled Timeline Compression, Titer, and Monoclonality
The current process of Cell Line Development is laborious, time consuming and screens only a limited number of CHO clones. With the Beacon platform, scientists can automate the process of cloning and screening of thousands of CHO clones under relevant media conditions. The result is better clones in less time with >99.5% documented clonality assurance.
Speaker: Keith Breinlinger, PhD, Chief Technology Officer at Berkeley Lights, Inc.